Skip to content

Drug interactions

Dihydroergotamine + Sotalol

Severity: Moderate

Dihydroergotamine and Sotalol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dihydroergotamine causes vasoconstriction, and beta-blockers may blunt beta-2-mediated vasodilation, so peripheral ischemia or vasospasm could be potentiated. The effect is reported mainly with ergot alkaloids and non-selective beta-blockers.

What this interaction means in plain words

Dihydroergotamine and Sotalol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dihydroergotamine belongs to Central Nervous System; Sotalol belongs to Cardiovascular.

Evidence level: Low

Why it happens

Ergot alpha-adrenergic vasoconstriction is unopposed when beta-2 vasodilation is blocked.

What to do

Monitor for cold extremities, paresthesias, or chest pain. Stop the ergot and seek review if ischemic symptoms develop.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dihydroergotamine and Sotalol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dihydroergotamine with Sotalol?

MediHelp rates the interaction as moderate. Dihydroergotamine and Sotalol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dihydroergotamine causes vasoconstriction, and beta-blockers may blunt beta-2-mediated vasodilation, so peripheral ischemia or vasospasm could be potentiated. The effect is reported mainly with ergot alkaloids and non-selective beta-blockers.

How serious is the interaction between Dihydroergotamine and Sotalol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for cold extremities, paresthesias, or chest pain. Stop the ergot and seek review if ischemic symptoms develop.

What other medicines interact with Sotalol?

MediHelp also lists interactions of Sotalol with, for example, Arsenic trioxide, Artemether / lumefantrine, Disopyramide. The full list is on the Sotalol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in